Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity?
| Image |  |
|---|---|
| Description | scientific article published on 01 February 2019 |
| Author/s |
author: Donna M. Mancini Juan Jose Badimon Valentín Fuster Carulla |
| Publication date | February 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |